FocusDrug Delivery Catering to chondrocytes Christopher H. EvansRehabilitation Medicine Research Center, Mayo Clinic, Rochester, MN 55905, USA.Email: evans.christopher{at}mayo.edu See allHide authors and affiliations Science Translational Medicine 28 Nov 2018:Vol. 10, Issue 469, eaav7043DOI: 10.1126/scitranslmed.aav7043 Christopher H. Evans Rehabilitation Medicine Research Center, Mayo Clinic, Rochester, MN 55905, USA.Find this author on Google Scholar Find this author on PubMed Search for this author on this site Article Figures & Data Info & Metrics eLetters PDF Article Information vol. 10 no. 469 DOI: https://doi.org/10.1126/scitranslmed.aav7043 PubMed: 30487250 Published By: American Association for the Advancement of Science Print ISSN: 1946-6234 Online ISSN: 1946-6242 History: Received for publication October 11, 2018Accepted for publication November 7, 2018 . Copyright & Usage: Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works http://www.sciencemag.org/about/science-licenses-journal-article-reuseThis is an article distributed under the terms of the Science Journals Default License. Author Information Christopher H. EvansRehabilitation Medicine Research Center, Mayo Clinic, Rochester, MN 55905, USA.Email: evans.christopher{at}mayo.edu Altmetric Article usage Article lifetimeLast 6 monthsThis monthArticle usage: November 2018 to March 2021 AbstractFullPdf Nov 201801564276 Dec 20185751747239 Jan 20192223526 Feb 20191281118 Mar 2019771524 Apr 2019391414 May 20194555 Jun 201934812 Jul 20194274 Aug 20192773 Sep 2019451215 Oct 201949179 Nov 201942910 Dec 20196074 Jan 202030268 Feb 20205276 Mar 2020321110 Apr 202047148 May 20204273 Jun 20201940 Jul 202017104 Aug 20201443 Sep 202024121 Oct 20203173 Nov 20202264 Dec 202029182 Jan 20213042 Feb 20215185 Mar 2021111 View Full Text
Catering to chondrocytes By Christopher H. Evans Science Translational Medicine28 Nov 2018 An innovative strategy for delivering drugs to chondrocytes in situ offers new avenues for treating osteoarthritis (Geiger et al., this issue).
Catering to chondrocytes By Christopher H. Evans Science Translational Medicine28 Nov 2018 An innovative strategy for delivering drugs to chondrocytes in situ offers new avenues for treating osteoarthritis (Geiger et al., this issue).